May 14th 2025
Despite holding promise in a range of disease states, a variety of challenges prevent cell and gene therapies (CGTs) from more widespread use, according to a new report from Cardinal Health.
Dr Elaine Siegfried on Considerations for Systemic Therapy Use in Pediatric Atopic Dermatitis
April 20th 2022Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, discusses several pediatric patient populations with atopic dermatitis who are candidates for the use of systemic therapies.
Watch
Ixekizumab Effective Long-term for Treatment of Psoriasis in Pediatric Patients
April 20th 2022Pediatric patients with psoriasis exhibited significant improvements in self-reported outcomes and objective measures of complete skin clearance when treated with ixekizumab vs placebo, with no new safety findings identified.
Read More
How Can the Health Care Industry Help Tackle Climate Change?
April 19th 2022In a talk presented by The Hastings Center, Gary Cohen, president of Health Care Without Harm, explains how the health care industry can fight climate change, mitigate social determinants of health, and reduce costs through a series of targeted efforts.
Read More
Contributor: Reform Medicare’s Payment Policy to Expand Patient Access to Nonopioids
April 17th 2022Addressing the opioid crisis will require a strong, multifaceted approach that includes efforts to prevent addiction before it begins. By passing the NOPAIN Act, Congress can seize the win-win opportunity to reduce unnecessary exposure to opioids, while protecting—and expanding—a patient’s right to choose their own care.
Read More
Dr Davey Daniel on Barriers Limiting Genomic Testing Use in Lung Cancer
April 17th 2022Davey Daniel, MD, chief medical officer, OneOncology, speaks on the knowledge, infrastructure, and payer-related barriers that are limiting the use of genomic testing in the management of patients with lung cancer.
Watch
City of Hope’s Alvarnas: Payers Must Recognize Cancer Care Is Different
April 17th 2022Joseph Alvarnas, MD, vice president of government affairs at City of Hope and chief clinical adviser of AccessHope in Duarte, California, spoke March 4 at the closing session of the Association for Community Cancer Centers (ACCC) Annual Meeting & Cancer Business Summit in Washington, DC.
Read More
Bristol Myers Squibb settles lawsuit on conspiring to block generic competition to HIV drugs; FDA grants emergency use authorization to a novel breath test that can detect COVID-19 within 3 minutes; health savings accounts (HSAs) are being used less effectively by minority and low-income populations.
Read More
Evidence, Support, and Education Needed to Drive Precision Oncology, Accenture’s Bogdan Says
April 14th 2022Accenture’s 2021 report, “The Future Is Now: How to Drive Precision Oncology Adoption," adds to the chorus calling for greater sharing of data and improved standardization, so that academic centers and community practices alike can continually improve data sets used worldwide.
Read More
Employer Utilization Management Prioritizes Health Benefit Cost Over Patient Care, Survey Finds
April 13th 2022Findings of a survey of large employers indicate that utilization management tools are ineffective in controlling health care costs for employees and may lead to barriers to treatment.
Read More
CRS With Nasal Polyps Linked With Reduced Health-Related QOL Across Patient Subgroups
April 13th 2022Reduced health-related quality of life was identified in patients with chronic rhinosinusitis with nasal polyps compared with the general population—regardless of previous sinus surgery or presence of comorbidities.
Read More
Biomarker Identifies CRSwNP Endotypes, Risk of Postoperative Nasal Polyp Recurrence
April 9th 2022Circulating B cell–activating factor was shown to be a potential biomarker in identifying blood eosinophil counts and risk of postoperative nasal polyp recurrence among patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Read More
Dr Robert Sidbury Discusses Impact of New AAD Guidelines on Atopic Dermatitis Treatment
April 8th 2022Robert Sidbury, MD, MPH, Chief, Division of Dermatology, Seattle Children's Hospital, discussed how new guidelines issued by the American Academy of Dermatology (AAD) regarding comorbidity risk in patients with atopic dermatitis will influence the condition's treatment.
Watch
Genomic Profiling Utility for Targeted Therapy Selection Shown in Advanced GI Cancers
April 8th 2022The clinical utility of genomic profiling was demonstrated in patients with advanced gastrointestinal (GI) cancers whose access to targeted therapies based on tissue-based assay findings was similar to those with non-GI cancers.
Read More
Incremental Steps Helpful but Not Enough to End Underinsurance Issue, Panelists Say
April 7th 2022Without addressing rising costs, the problem of underinsurance in health care coverage will remain, said panelists at the 2022 V-BID Summit, discussing some of the smaller steps that are being proposed or are already in place to try to ease the financial burden.
Read More
Dr Stephen Rozzo on Regulatory Nature of Tildrakizumab for Psoriasis
April 7th 2022Stephen Rozzo, PhD, associate vice president and head, Biologics Medical Affairs, Sun Pharma, North America, explains tildrakizumab’s mechanisms of action in the treatment of psoriasis and how the drug differs from other approved biologics.
Watch
Increasing Health Equity to Reduce Disparities in Value-Based Care
April 7th 2022At the 2022 V-BID Summit, hosted by the Center for Value-Based Insurance Design at the University of Michigan, representatives of CMS and the Commonwealth Fund gave an update on the efforts to monitor, evaluate, and improve health equity in the United States.
Read More
Baricitinib Linked With Improved Skin Pain Severity, Positive QOL in Atopic Dermatitis
April 5th 2022Patients with atopic dermatitis who achieved rapid changes in skin pain severity with the Janus kinase inhibitor baricitinib were associated with clinically significant improvement in Dermatology Life Quality Index scores.
Read More
What We're Reading: ACA Coverage Expansion; New Heart Failure Guidelines; Poor Air Quality Worldwide
April 5th 2022The Biden administration plans to expand Affordable Care Act (ACA) coverage to more families; new guidelines jointly announced by cardiology organizations for the treatment and prevention of heart failure; World Health Organization estimates that 99% of people worldwide are exposed to poor air quality.
Read More
Examining the Impact of Psoriasis Disease Burden on QOL, Mental Health
April 4th 2022Two abstracts presented at the 2022 American Academy of Dermatology (AAD) Annual Meeting explored the health-related quality of life (QOL) and mental health impact of psoriasis disease burden by severity and affected body region.
Read More